Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Pavaki Capital Management LLC - 31 Dec 2025 SCHEDULE 13G Report for Milestone Pharmaceuticals Inc. Common Shares, no par value (MIST)
- Filing manager
- Pavaki Capital Management LLC
- Reporting owner
- Pavaki Capital Management LLC
- Beneficially owned shares
- 9,067,848 shares
- Large-stake signal
-
Ownership
7.3%Beneficial ownership of this reported class.
Shares
9,067,848 sharesShares beneficially owned as disclosed.
Event date
31 Dec 2025Date tied to the ownership event or amendment.
Accepted by SEC
07 Aug 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 7.3%
- Symbol
- MIST
- Shares outstanding
- 124,217,096 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 07 Aug 2026, 13:49:31 UTC
- Event date
- 31 Dec 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Pavaki Capital Management LLC disclosed 7.3% ownership in Milestone Pharmaceuticals Inc. Common Shares, no par value (MIST) on 31 Dec 2025.
Key facts
- Pavaki Capital Management LLC filed SCHEDULE 13G for Milestone Pharmaceuticals Inc. Common Shares, no par value (MIST).
- Disclosed ownership: 7.3%.
- Date of event: 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Aug 2026, 13:49.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (3)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Pavaki Capital Management LLC | 7.3% | 9,067,848 | 0 | 9,067,848 | Ashok Rambhai Patel | Ashok Rambhai Patel, Managing Member | |
| Pavaki Capital Partners, LP | 7.3% | 9,067,848 | 0 | 9,067,848 | Ashok Rambhai Patel | Ashok Rambhai Patel, Managing Member of Pavaki Capital Management, LLC, its General Partner | |
| Ashok Rambhai Patel | 7.3% | 9,067,848 | 0 | 9,067,848 | Ashok Rambhai Patel | Ashok Rambhai Patel, Individually |
CIK / CUSIP context first